Amedisys, Inc. (AMED)
USD 91.83
(0.08%)
USD 91.83
(0.08%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 341.35 Million USD | -31.37% |
| 2022 | 497.4 Million USD | -1.1% |
| 2021 | 502.91 Million USD | 123.29% |
| 2020 | 225.23 Million USD | -23.85% |
| 2019 | 295.78 Million USD | 2403.27% |
| 2018 | -12.84 Million USD | -618.24% |
| 2017 | 2.47 Million USD | -96.06% |
| 2016 | 62.83 Million USD | -13.33% |
| 2015 | 72.49 Million USD | -33.08% |
| 2014 | 108.34 Million USD | 245.02% |
| 2013 | 31.4 Million USD | -64.86% |
| 2012 | 89.36 Million USD | -8.28% |
| 2011 | 97.43 Million USD | 58.25% |
| 2010 | 61.57 Million USD | -65.92% |
| 2009 | 180.66 Million USD | -44.53% |
| 2008 | 325.72 Million USD | 1113.15% |
| 2007 | -32.15 Million USD | 59.24% |
| 2006 | -78.88 Million USD | -269.54% |
| 2005 | 46.52 Million USD | 154.19% |
| 2004 | -85.85 Million USD | -299.32% |
| 2003 | -21.5 Million USD | -405.67% |
| 2002 | 7.03 Million USD | -68.51% |
| 2001 | 22.33 Million USD | 144.58% |
| 2000 | 9.13 Million USD | -62.12% |
| 1999 | 24.1 Million USD | -10.7% |
| 1998 | 26.99 Million USD | 366.07% |
| 1997 | 5.79 Million USD | -8.55% |
| 1996 | 6.33 Million USD | 71.17% |
| 1995 | 3.7 Million USD | 32.14% |
| 1994 | 2.8 Million USD | 366.67% |
| 1993 | 600 Thousand USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 317.28 Million USD | -12.14% |
| 2024 Q1 | 361.11 Million USD | 5.79% |
| 2023 Q1 | 436 Million USD | -12.34% |
| 2023 Q3 | 412.09 Million USD | 5.29% |
| 2023 Q2 | 391.4 Million USD | -10.23% |
| 2023 Q4 | 341.35 Million USD | -17.17% |
| 2023 FY | 341.35 Million USD | -31.37% |
| 2022 Q3 | 544 Million USD | 1.68% |
| 2022 FY | 497.4 Million USD | -1.1% |
| 2022 Q1 | 476.12 Million USD | -5.33% |
| 2022 Q2 | 535.02 Million USD | 12.37% |
| 2022 Q4 | 497.4 Million USD | -8.57% |
| 2021 Q2 | 191.97 Million USD | -25.53% |
| 2021 Q3 | 422.82 Million USD | 120.25% |
| 2021 FY | 502.91 Million USD | 123.29% |
| 2021 Q1 | 257.77 Million USD | 14.45% |
| 2021 Q4 | 502.91 Million USD | 18.94% |
| 2020 Q2 | 317.71 Million USD | 6.37% |
| 2020 Q4 | 225.23 Million USD | -22.7% |
| 2020 Q3 | 291.36 Million USD | -8.29% |
| 2020 Q1 | 298.69 Million USD | 0.98% |
| 2020 FY | 225.23 Million USD | -23.85% |
| 2019 Q1 | 380.57 Million USD | 3063.49% |
| 2019 FY | 295.78 Million USD | 2403.27% |
| 2019 Q4 | 295.78 Million USD | -2.46% |
| 2019 Q2 | 343.75 Million USD | -9.67% |
| 2019 Q3 | 303.24 Million USD | -11.78% |
| 2018 Q2 | 98.7 Million USD | 391.96% |
| 2018 Q3 | 42.05 Million USD | -57.39% |
| 2018 Q4 | -12.84 Million USD | -130.54% |
| 2018 Q1 | -33.8 Million USD | -1464.25% |
| 2018 FY | -12.84 Million USD | -618.24% |
| 2017 Q2 | 32.13 Million USD | -27.02% |
| 2017 Q3 | 23.79 Million USD | -25.94% |
| 2017 Q4 | 2.47 Million USD | -89.59% |
| 2017 Q1 | 44.02 Million USD | -29.93% |
| 2017 FY | 2.47 Million USD | -96.06% |
| 2016 FY | 62.83 Million USD | -13.33% |
| 2016 Q3 | 85.17 Million USD | 0.77% |
| 2016 Q4 | 62.83 Million USD | -26.24% |
| 2016 Q1 | 102.74 Million USD | 41.72% |
| 2016 Q2 | 84.53 Million USD | -17.72% |
| 2015 Q2 | 62.31 Million USD | -34.62% |
| 2015 Q1 | 95.31 Million USD | -12.03% |
| 2015 FY | 72.49 Million USD | -33.08% |
| 2015 Q4 | 72.49 Million USD | 68.8% |
| 2015 Q3 | 42.94 Million USD | -31.08% |
| 2014 Q2 | 133.05 Million USD | 231.7% |
| 2014 Q4 | 108.34 Million USD | -0.38% |
| 2014 FY | 108.34 Million USD | 245.02% |
| 2014 Q1 | 40.11 Million USD | 27.74% |
| 2014 Q3 | 108.75 Million USD | -18.26% |
| 2013 Q3 | 27.22 Million USD | -39.07% |
| 2013 FY | 31.4 Million USD | -64.86% |
| 2013 Q2 | 44.68 Million USD | -37.71% |
| 2013 Q4 | 31.4 Million USD | 15.32% |
| 2013 Q1 | 71.73 Million USD | -19.73% |
| 2012 Q4 | 89.36 Million USD | 2.15% |
| 2012 Q1 | 95.59 Million USD | -1.88% |
| 2012 Q2 | 91.24 Million USD | -4.56% |
| 2012 Q3 | 87.48 Million USD | -4.12% |
| 2012 FY | 89.36 Million USD | -8.28% |
| 2011 Q1 | 23.37 Million USD | -62.04% |
| 2011 FY | 97.43 Million USD | 58.25% |
| 2011 Q2 | 135.21 Million USD | 478.57% |
| 2011 Q3 | 123.78 Million USD | -8.45% |
| 2011 Q4 | 97.43 Million USD | -21.29% |
| 2010 FY | 61.57 Million USD | -65.92% |
| 2010 Q1 | 121.4 Million USD | -32.8% |
| 2010 Q2 | 88.09 Million USD | -27.43% |
| 2010 Q4 | 61.57 Million USD | -4.84% |
| 2010 Q3 | 64.7 Million USD | -26.56% |
| 2009 Q2 | 240.8 Million USD | -15.57% |
| 2009 Q4 | 180.66 Million USD | 1.47% |
| 2009 Q3 | 178.05 Million USD | -26.06% |
| 2009 Q1 | 285.21 Million USD | -12.44% |
| 2009 FY | 180.66 Million USD | -44.53% |
| 2008 FY | 325.72 Million USD | 1113.15% |
| 2008 Q1 | 392.19 Million USD | 1319.88% |
| 2008 Q2 | 377.53 Million USD | -3.74% |
| 2008 Q3 | 354.06 Million USD | -6.22% |
| 2008 Q4 | 325.72 Million USD | -8.0% |
| 2007 Q2 | -76.04 Million USD | 24.82% |
| 2007 FY | -32.15 Million USD | 59.24% |
| 2007 Q3 | -42.91 Million USD | 43.57% |
| 2007 Q1 | -101.14 Million USD | -28.22% |
| 2007 Q4 | -32.15 Million USD | 25.08% |
| 2006 Q1 | 62.1 Million USD | 33.48% |
| 2006 FY | -78.88 Million USD | -269.54% |
| 2006 Q2 | 50.32 Million USD | -18.96% |
| 2006 Q3 | 44.21 Million USD | -12.15% |
| 2006 Q4 | -78.88 Million USD | -278.42% |
| 2005 Q3 | 43.98 Million USD | 166.33% |
| 2005 FY | 46.52 Million USD | 154.19% |
| 2005 Q4 | 46.52 Million USD | 5.79% |
| 2005 Q2 | -66.31 Million USD | 9.18% |
| 2005 Q1 | -73.01 Million USD | 14.96% |
| 2004 Q1 | -17.31 Million USD | 19.48% |
| 2004 FY | -85.85 Million USD | -299.32% |
| 2004 Q4 | -85.85 Million USD | 1.1% |
| 2004 Q3 | -86.81 Million USD | -424.86% |
| 2004 Q2 | -16.54 Million USD | 4.45% |
| 2003 Q2 | -3.69 Million USD | -254.25% |
| 2003 Q1 | 2.39 Million USD | -65.91% |
| 2003 Q4 | -21.5 Million USD | -1861.77% |
| 2003 FY | -21.5 Million USD | -405.67% |
| 2003 Q3 | -1.09 Million USD | 70.37% |
| 2002 Q4 | 7.03 Million USD | -36.53% |
| 2002 Q2 | 10.98 Million USD | -32.54% |
| 2002 Q1 | 16.27 Million USD | -27.12% |
| 2002 FY | 7.03 Million USD | -68.51% |
| 2002 Q3 | 11.08 Million USD | 0.94% |
| 2001 Q3 | 1.65 Million USD | -89.24% |
| 2001 FY | 22.33 Million USD | 144.58% |
| 2001 Q2 | 15.4 Million USD | 50.43% |
| 2001 Q1 | 10.23 Million USD | 12.12% |
| 2001 Q4 | 22.33 Million USD | 1247.92% |
| 2000 FY | 9.13 Million USD | -62.12% |
| 2000 Q2 | 19.19 Million USD | -15.38% |
| 2000 Q4 | 9.13 Million USD | -43.16% |
| 2000 Q3 | 16.06 Million USD | -16.29% |
| 2000 Q1 | 22.68 Million USD | 284.46% |
| 1999 Q1 | 30.7 Million USD | 13.72% |
| 1999 Q4 | 5.9 Million USD | -78.15% |
| 1999 Q3 | 27 Million USD | -33.0% |
| 1999 FY | 24.1 Million USD | -10.7% |
| 1999 Q2 | 40.3 Million USD | 31.27% |
| 1998 FY | 26.99 Million USD | 366.07% |
| 1998 Q3 | 11.5 Million USD | 0.88% |
| 1998 Q4 | 26.99 Million USD | 134.74% |
| 1998 Q1 | 6.1 Million USD | 5.32% |
| 1998 Q2 | 11.4 Million USD | 86.89% |
| 1997 Q3 | 6.7 Million USD | -2.9% |
| 1997 Q2 | 6.9 Million USD | -14.81% |
| 1997 FY | 5.79 Million USD | -8.55% |
| 1997 Q1 | 8.1 Million USD | 27.9% |
| 1997 Q4 | 5.79 Million USD | -13.55% |
| 1996 Q2 | 6.3 Million USD | 23.53% |
| 1996 Q3 | 4.3 Million USD | -31.75% |
| 1996 FY | 6.33 Million USD | 71.17% |
| 1996 Q1 | 5.1 Million USD | 37.84% |
| 1996 Q4 | 6.33 Million USD | 47.28% |
| 1995 FY | 3.7 Million USD | 32.14% |
| 1995 Q2 | 4.2 Million USD | 50.0% |
| 1995 Q1 | 2.8 Million USD | 0.0% |
| 1995 Q3 | 2.9 Million USD | -30.95% |
| 1995 Q4 | 3.7 Million USD | 27.59% |
| 1994 FY | 2.8 Million USD | 366.67% |
| 1994 Q4 | 2.8 Million USD | 0.0% |
| 1994 Q2 | 1.9 Million USD | 26.67% |
| 1994 Q1 | 1.5 Million USD | 150.0% |
| 1993 FY | 600 Thousand USD | 0.0% |
| 1993 Q4 | 600 Thousand USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 1.41 Billion USD | 75.802% |
| Addus HomeCare Corporation | 110.39 Million USD | -209.219% |
| AirSculpt Technologies, Inc. | 89.4 Million USD | -281.798% |
| American Oncology Network, Inc. | 99.78 Million USD | -242.082% |
| Astrana Health, Inc. | 27.2 Million USD | -1154.64% |
| Aveanna Healthcare Holdings Inc. | 1.45 Billion USD | 76.544% |
| IMAC Holdings, Inc. | -221.51 Thousand USD | 154200.699% |
| biote Corp. | 25.86 Million USD | -1219.533% |
| Cryo-Cell International, Inc. | 10.48 Million USD | -3154.063% |
| Cross Country Healthcare, Inc. | -11.82 Million USD | 2986.193% |
| COMPASS Pathways plc | -187.58 Million USD | 281.968% |
| DocGo Inc. | -12.78 Million USD | 2769.09% |
| The Ensign Group, Inc. | 1.36 Billion USD | 74.932% |
| Healthcare Services Group, Inc. | -10.69 Million USD | 3291.678% |
| InnovAge Holding Corp. | 56.08 Million USD | -508.586% |
| Assure Holdings Corp. | 14.68 Million USD | -2224.956% |
| The Joint Corp. | -2.47 Million USD | 13867.111% |
| LifeStance Health Group, Inc. | 432.21 Million USD | 21.024% |
| Mobile-health Network Solutions Class A Ordinary Shares | -6.05 Million USD | 5741.625% |
| ModivCare Inc. | 1.13 Billion USD | 69.986% |
| NewGenIvf Group Limited | 278.44 Thousand USD | -122489.774% |
| Novo Integrated Sciences, Inc. | 4.05 Million USD | -8317.326% |
| Option Care Health, Inc. | 822.56 Million USD | 58.502% |
| P3 Health Partners Inc. | 83.7 Million USD | -307.791% |
| P3 Health Partners Inc. | 83.7 Million USD | -307.791% |
| The Pennant Group, Inc. | 323.57 Million USD | -5.494% |
| Surgery Partners, Inc. | 2.86 Billion USD | 88.088% |
| Syra Health Corp. Class A Common Stock | -3.03 Million USD | 11358.349% |
| Talkspace, Inc. | -123.9 Million USD | 375.487% |
| Talkspace, Inc. | -123.9 Million USD | 375.487% |
| The Oncology Institute, Inc. | 86.32 Million USD | -295.415% |
| The Oncology Institute, Inc. | 86.32 Million USD | -295.415% |